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Abstract
The phosphoinositide (PI) cycle is an important signal transduction pathway that, upon activation, generates intracellular second
messengers and leads to calcium release. To determine whether PI cycle-mediated intracellular calcium release is required for body plan
formation, we systematically dissect PI cycle function in the zebrafish (Danio rerio). We inhibit PI cycle function at three different steps
and deplete internal calcium stores, demonstrating an impact on endogenous calcium release and Wnt/-catenin signaling. Inhibition of
endogenous calcium modulation induces hyperdorsalized phenotypes in a dose-dependent manner. Ectopic dorsal-signaling centers are
generated in PI cycle-inhibited embryos as demonstrated by altered -catenin subcellular localization and ectopic expression of -catenin
target genes. These results provide evidence that modulation of calcium release is critical for early embryonic patterning and acts by
influencing the stabilization of -catenin protein.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Receptor stimulation of the phosphatidylinositol (PI) cy-
cle activates a phosphatidylinositol-specific phospholipase
(PI-PLC) which hydrolyses the membrane phospholipid,
phosphatidlyinositol (4,5) bisphosphate (PIP2), and gener-
ates inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(Berridge et al., 1989; Berridge, 1993). Intracellular calcium
release in nonexcitable cells is thought to occur predomi-
nantly through specialized ligand-gated channels, such as
the IP3 Receptor (IP3R), in response to relatively low
threshold IP3 levels (Parekh et al., 1997; Scharenberg and
Kinet, 1998). IP3 bound to the IP3R on the endoplasmic
reticulum (ER) activates the release of calcium into the
cytosol (Fig. 1). This modulates the properties and activities
of many downstream targets (Berridge, 1998). Biosynthesis
and turnover of inositol, mediated by inositol monophos-
phatase, is required for continued PI cycle signaling.
Initial evidence linking PI cycle activity to body plan
formation came from classical studies with lithium-treated
embryos. In Xenopus, lithium treatment of cleavage-stage
embryos produced a secondary axis and rescued UV-ven-
tralized embryos (Kao et al., 1986; Kao and Elinson, 1989,
1998). Global treatment with externally supplied lithium to
zebrafish at the 32-cell stage dorsalized embryos as shown
by the expansion of the dorsal specific probe goosecoid
(Stachel et al., 1993). Injection of lithium into a single cell
on one side at the 32-cell stage generated dorsalized em-
bryos 50% of the time, suggesting that only one side (pre-
sumably ventral) of the zebrafish embryo is sensitive to
lithium. The asymmetric response to lithium was confirmed
in two manners: (1) injection into single cells on both sides
of the embryo at the 32-cell stage resulted in 100% hyper-
dorsalization and (2) cell labeling demonstrating lithium
sensitivity is localized to cells of ventral lineage (Aanstad
and Whitaker, 1999). It has been proposed that lithium
treatment inhibits inositol turnover by preventing the gen-
eration of free inositol and its subsequent recycling back
into the membrane (Berridge et al., 1989). The previously
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discussed data, coupled with the observation of increased
IP3 levels in Xenopus and zebrafish embryos during the
cleavage stage, are consistent with the theory that lithium
inhibition of PI cycle activity generates early D-V pattern-
ing defects (Busa and Gimlich, 1989; Maslanski et al., 1992;
Reinhard et al., 1995). This conclusion is supported by the
ability to rescue lithium-induced dorsal expansion pheno-
types with a PI cycle intermediate (myo-inositol) (Busa and
Gimlich, 1989). In addition, Xenopus embryos injected with
antibodies that disrupt IP3 Receptor (IP3R) function display
expanded dorsal structures with a loss of ventral tissues
(Kume et al., 1997). These data were taken as evidence that
PI cycle activity is required for defining the dorsal–ventral
(D-V) axis.
Lithium has been shown to act on numerous molecular
targets, including G-proteins, adenyl cyclase, protein Ki-
nase C (Manji et al., 1997; Saito et al., 1995), and glycogen
synthase kinase-3 (Gsk-3) (Klein and Melton, 1996; Stam-
bolic et al., 1996). Gsk-3 is a constitutively active kinase
that negatively regulates its substrates, one of which is
-catenin, a downstream effector of the canonical Wnt path-
way (Fig. 1). Inhibition of Gsk-3 function leads to accumu-
lation of -catenin protein and generates an ectopic dorsal
axis. Thus, it was proposed that the dorsalizing effect of
lithium treatment was mediated by Gsk-3 inhibition. It is
important to note that the dorsalizing effects of Gsk-3 in-
hibition, via injection of a dominant negative construct
(dnGsk-3), are rescued with a PI cycle intermediate (myo-
inositol) (Hedgepeth et al., 1997). Additionally, recent stud-
ies of mood-stabilizing drugs used to treat bipolar affective
disorder identified that the common mechanism of action
for lithium and the other drugs is inositol depletion (Wil-
liams et al., 2002).
The Wnt gene family of secreted glycoproteins can be
grouped into mechanistically distinct classes based on over-
expression assays (Du et al., 1995; Moon et al., 1993; Wong
et al., 1994). The canonical Wnt class (also referred to as
Wnt/-catenin; Fig. 1A) consists of the Drosophila wing-
less (wg) and vertebrate Wnt-1 and -8 (Dale, 1998). In
vertebrate embryos, Wnt/-catenin overexpression induces
ectopic axes (Du et al., 1995; Moon et al., 1993; Torres et
al., 1996). Stimulation of the canonical Wnt path activates a
cytoplasmic phosphoprotein (Dishevelled, Dsh), which then
inhibits the function of a degradation complex, including
glycogen synthase kinase 3 (Gsk3) (Wharton, 2003). Down-
regulation of Gsk-3 activity leads to accumulation of
-catenin, a multifunctional protein that interacts with cad-
herins as well as transcription factors (LEF-TCF DNA bind-
ing proteins) influencing gene expression (Moon et al.,
2002).
The common element of noncanonical Wnt signaling is
that this class (including Wnt-5A, -4, and -11) appears to be
-catenin-independent (Kuhl et al., 2000b). Noncanonical
Wnt activity can branch into several cellular outputs iden-
tified by calcium modulation and polarized cell movement
(Wnt/Ca2 and Planar Cell Polarity; Mlodzik, 2002). We
have shown that ectopic expression of the noncanonical
Wnt, Wnt-5A, stimulates PI cycle-mediated Ca2 release.
Both misexpression of Wnt-5A and artificial stimulation of
calcium release are antagonistic to canonical Wnt (Wnt/-
catenin) activity (Slusarski et al., 1997b) (Fig. 1). If the
antagonistic interaction between the non canonical Wnt-5A
and canonical Wnt classes is due to calcium modulation, we
predict that loss of PI cycle-mediated calcium release will
result in ectopic activation of the Wnt/-catenin path. Sev-
eral nonoverlapping PI cycle inhibitors and one general
Ca2 release inhibitor are used to specifically address the
requirement for PI cycle activity and the importance of
intracellular Ca2 release during early embryonic develop-
ment. We target three steps in the PI-pathway: the enzyme
Phospholipase C (PLC), the IP3 Receptor (IP3R), and ino-
sitol monophosphatase and deplete Ca2 stores with the
ER-specific Ca2-ATPase inhibitor thapsigargin (Fig. 1, red
circles). We then analyze the extent of inhibition by observ-
Fig. 1. Schematic of the stimulation of canonical and noncanonical Wnt signaling pathway. Only a few of the known players are highlighted. Gsk is the only
member of the degradation complex shown. The cellular pools of -catenin are represented as the plasma membrane cadherin-associated, the cytoplasmic,
and the nuclear. Red circles note sites of inhibition. (A) is at the level of PLC activity, (B) at the IP3R, and (C) at the inositol turnover. The site where
myo-inositol rescue acts is noted.
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ing calcium release in vivo and the resultant phenotypes in
the zebrafish (Danio rerio).
In this work, we demonstrate an impact on D-V pattern-
ing, specifically the subcellular localization of -catenin
protein and ectopic expression of -catenin target genes in
PI cycle-inhibited and Ca2-depleted embryos. Therefore,
modulation of Ca2 release is critical during early embry-
onic pattern formation and acts, in part, by influencing
Wnt/-catenin signaling.
Materials and methods
Embryo preparation
Fertilized eggs were collected from the natural spawning
of adult wild-type zebrafish. Embryos were rinsed with egg
medium (Westerfield, 1995) and staged (according to Kim-
mel et al., 1995). Zebrafish embryos were microinjected via
a pressure injector (Harvard Apparatus) with approximately
100 picoliter (pl) volumes at the 1-cell stage and 50-100 pl
at the 8- to 32-cell stage. Live embryos were photographed
with Nomarski optics after orienting in 3% methylcellulose
between bridged coverslips.
Pharmacological reagents
L-690,330 stock, 20 mM in 1  PBS, was made fresh
each time for working concentrations of 0.1–10 mM. Con-
trol injections were 10 mM L-690,330 mixed with 50 mM
myo-inositol. The L-690,330 solution was combined with
injection dye (0.05% buffered phenol red) and microin-
jected into embryos. For calcium image analysis, L-690,330
was combined with Fura-2 (dextran-conjugated, 10,000 Mr,
Molecular Probes) and injected into 1-cell-stage embryos or
combined with Texas-red lineage marker (TxR-conjugated
dextran: 10,000 Mr, Molecular Probes) and injected into 8-
to 16-cell-stage embryos.
The monoclonal antibody mAb 1G9 (3–6 ng/embryo)
(generously provided by Dr. Kume) (Kume et al., 1997) was
mixed with 1  PBS and injection dye for morphological
and confocal analyses or mixed with Texas-red lineage
marker (TxR-conjugated dextran: 10,000 Mr, Molecular
Probes) for calcium image analysis. Mouse monoclonal IgG
and Endoplasmic Reticulum-specific (H-69) was injected as
a control.
Stock solutions of U-73122 (10 mM; BIOMOL), (1-(6-
((17-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-
1H-pyrrole-2,5-dione), its biologically inactive control an-
alog U-73343 (BIOMOL), or thapsigargin (2.5–5 M; Mo-
lecular Probes) were diluted in egg medium. Thirty-two-cell
zebrafish embryos were incubated in a 10 M solution of
U-73122 or U-73343 for 30–60 min and then washed with
egg medium. Then, 32- to 64-cell-stage embryos were in-
cubated in 2.5–5 M thapsigargin for 60 min and then
washed several times in egg water. After treatment, em-
bryos were cultured at 28°C to the somite stage for live
photography or fixed at an earlier stage for whole-mount in
situ hybridization.
For Ca2 analysis, thapsigargin, U-73122, or U-73343
was slowly added to the imaging chamber after the endog-
enous activity was noted for Fura-injected embryos.
Calcium image analysis
Inhibitors were either coinjected with the Fura-2 (final
concentration 25 M) or injected after the 4- to 8-cell
stage with a Texas Red lineage marker (TxR). Shortly after
injection (16- to 32-cell stage), embryos were oriented in a
lateral position in a coverslip-bottomed chamber on a Zeiss
axiovert 100 epifluorescence microscope. Data were col-
lected at 10- to 15-s intervals with a Quantix digital cooled
CCD camera as image pairs at 340 and 380-nm excitation
wavelengths (510-nm emission). The imaging session lasted
from 45 to 75 min during the cellular blastoderm stage.
Ratio images were calculated by the computer software
Ratio Tool (Inovision). If needed, TxR distribution was
determined by collecting a reference exposure at 540-nm
excitation. In experiments that involve addition of inhibitor
to the chamber, the imaging session was initiated and data
collected for 10–20 min. After the baseline activity was
established, inhibitor was slowly added to the chamber
while continuously collecting image pairs for an additional
40–55 min. Changes in Ca2 release dynamics were deter-
mined by using subtractive analog analysis (described in
Slusarski and Corces, 2000). A calcium transient was de-
fined as a feature the size of a cell with a significant increase
in fluorescence intensity. The number of features (tran-
sients) was complied and compared with control-injected or
wild-type embryos. The images are of lateral views of
whole embryos, and endogenous Ca2 transient activity
during the cellular blastoderm stage does not have any
obvious D-V asymmetry (Reinhard et al., 1995; Slusarski et
al., 1997b). In embryos unilaterally injected with a reagent,
we use the other half as control for activity (Liu et al., 1999;
Slusarski et al., 1997a).
Whole-mount in situ hybridization
For all manipulations, embryos at the appropriate devel-
opmental stage, sphere/dome (4 h postfertilization, hpf) or
50% epiboly (5.25 hpf) were placed in 4% paraformalde-
hyde/PBS fixative. Digoxygenin-UTP-labeled RNA probes
(Roche) were synthesized by using: SP6 RNA polymerase
from NotI linearized bozozok (Fekany et al., 1999) and T7
RNA polymerase from SpeI-digested chordin (Miller-Ber-
toglio et al, 1997) templates. Single-probe hybridizations
were done as described in Thisse et al. (1993). After probe
detection, embryos were mounted and photographed. For
the heme staining, whole embryos after the 15-somite stage
were stained for hemoglobin by o-Dianisidine as described
in (Huber and Zon, 1998; Iuchi and Yamamoto, 1983).
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Immunolocalization
Embryos were fixed in 4% paraformaldehyde/1  PBS
at the sphere/dome stage (4 hpf). For immunolocalization of
-catenin, embryos were incubated overnight in a 1:75
dilution of a rabbit polyclonal antibody (P14L; generously
provided by Dr. Kurth) (Schneider et al., 1996), followed by
overnight incubation with 1:500 dilution of goat anti-rabbit
secondary antibody conjugated with a fluorescent label
(Texas-red or Alexa633; Molecular Probes). Nuclei were
identified by counter-stain with the indicator dye Sytox
Green (Molecular Probes). Embryos were incubated in 5
M Sytox/1 PBS for 20 min at room temperature. Indi-
vidual nuclei can be imaged simultaneously with the anti-
body staining by using two-channel imaging on a Leica
TCS-NT scanning laser confocal microscope system using
20/0.7 Plan Apo and 63/1.2 water objectives. Whole-
mount embryos in an animal pole orientation were optically
sectioned with increasing depth of focus at 4-micron inter-
vals. The image stacks were evaluated and nuclear -cate-
nin in nonoverlapping cells was counted as positive. When
embryo mounts were larger than the lens field, several fields
of view were collected and made into a montage to repre-
sent the entire circumference.
Results
Inhibition of inositol turnover
Inositol monophosphatase is a key enzyme in the PI
cycle responsible for hydrolysis of inositol monophosphates
to generate free inositol. Inhibition of this step reduces
levels of free inositol leading to inositol depletion and the
subsequent inhibition of PI cycle function. The bisphospho-
nate compound L-690,330 is a competitive inhibitor of
inositol monophosphatase (IMPase) (Atack et al., 1993).
Since injection of 1–10 mM L-690,330 into Xenopus em-
bryos did not generate any noticeable phenotype (Klein and
Melton, 1996), we decided to test the potency of the
L-690,330 reagent by monitoring endogenous calcium re-
lease activity, shortly after the drug was introduced and for
the duration of the cellular blastoderm stage. The frequency
of calcium release in L-690,330-injected embryos (average
of 0.7 new transients/min) is less than half the activity of
wild-type embryos (average of 2 new transients/min). Inhi-
bition of the transient activity was noted shortly after injec-
tion of the reagent. L-690,330 has an IC50 of 0.33 M; 10
mM doses have been shown to inhibit inositol turnover
leading to inositol depletion in Chinese Hamster Ovary cells
(Atack et al., 1993). In support of the inositol depletion
conclusion, we were able to rescue the L-690,330-induced
suppression of Ca2 release by coinjection of myo-inositol.
One key observation derived from the image analysis is the
duration of inhibition on endogenous activity. Although the
duration increases with dose, such that 2-6 mM and 6–10
mM L-690,330 inhibit intracellular Ca2 release for 8–10
min and 20–40 min, respectively, it does not persist for the
length of the cellular blastoderm stage.
Having determined that L-690,330 treatment results in a
suppression of calcium release, we next analyzed the mor-
phological impact of L-690,330 treatment in zebrafish em-
bryos. Embryos are injected with L-690,330 and the
strength of the resultant phenotype is characterized by how
the notochord, somites, and tail are affected when compared
with wild-type or control-injected embryos.
In wild-type (Fig. 2A) and control-injected (Fig. 2C)
embryos, dorsal and ventral tissues are present in the tail,
and both extend posteriorly off of the yolk. Embryos mi-
croinjected with 3 mM L-690,330 display mild tail defects
due to the loss of ventral tail tissue (Fig. 2B), while embryos
exposed to a higher dose (6 mM) lack more tail structures,
resulting in the curling of the tail and an enlarged pericardial
cavity (data not shown). Exposure to a moderate to high
dose (8–10 mM) generates a swirling of the tail over the
trunk of the embryo phenotype, resembling the snailhouse
dorsalized mutant (Fig. 2D) (Mullins et al., 1996). At 24 hpf
in wild-type and control-injected embryos, the notochord is
a thin, rod-like structure along the dorsal midline (Fig. 2E,
arrowheads) with somites forming as blocks of tissue to
each side (Fig. 2E, stars). At 10–12 mM L-690,330 doses,
severe defects are observed, including lateral expansion of
the somites (Fig. 2F, stars), a broadened notochord (Fig. 2G,
arrows), and a twisting of the axis.
Since the L-690,330-induced embryonic defects are sim-
ilar to the spectrum of dorsalized defects in genetic muta-
tions described and classified by Mullins et al. (1996), we
employed a similar scoring scheme (summarized in Table
1). The dorsalized mutations were classified with the weak-
est classes displaying loss of ventral tissue in the tail fin and
reduced circulation (C1 and C2), while moderate dorsaliza-
tion defects include curling of the tail over the trunk instead
of the normal extension off of the yolk (C3). And extreme
defects (C4 and C5) include ovoid-shaped embryos, lateral
expansion of somites around the circumference of the yolk,
thickened notochord, and twisted trunk axis (Mullins et al.,
1996).
Additionally, treated embryos had reduced circulation
most likely due to the expansion of dorsal tissue was at the
expense of ventral specific tissue, such as blood progenitors.
To test for loss of blood progenitors, we determined the
number of blood cells by o-Dianisidine staining for hemo-
globin in whole embryos after the 15-somite stage (Huber
and Zon, 1998; Iuchi and Yamamoto, 1983). We found that
L-690,330-injected embryos had few or no blood cells
present (data not shown).
As stated earlier, the same doses of L-690,330 did not
generate a phenotype in Xenopus embryos (Klein and Melton,
1996). However, we determined, by monitoring changes to
endogenous levels, that calcium fluxes are suppressed, at least
partially, and we observe dorsalized phenotypes. One expla-
nation for the discrepancy is that the same drug concentration,
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in the larger volume Xenopus embryo, may only impact en-
dogenous activity for a brief duration. Although inositol turn-
over inhibition was monitored in vitro on the L-690,330-in-
jected Xenopus embryos 10 min after injection, the impact on
in vivo activity later than that time point was not determined
(Klein and Melton, 1996).
Inhibition of IP3 Receptor function
To further demonstrate the requirement for PI cycle
function in D-V patterning, we target a different step in the
cycle. The IP3 Receptor (IP3R) plays a central role in the
initiation and propagation of agonist-mediated calcium re-
lease from intracellular stores. Two different reagents were
used to inhibit IP3R function: (1) A pharmacological re-
agent, Xestospongin C (Calbiochem) and (2) Blocking an-
tibody to the Xenopus IP3R (mAb 1G9) (Kume et al., 1997).
Mouse monoclonal antibodies were used as a control for
1G9 blocking antibody.
Xestospongin C (XeC), a macrocyclic bis-1-oxaquinoli-
zidine, inhibits IP3-induced calcium release and is proposed
Fig. 2. Range of morphological phenotypes induced by PI cycle inhibition. Lateral view with anterior to the right of live embryos approximately 48 hpf (A–D).
(A) Untreated. (B) L-690,330-injected (3–6 mM) with reduced tail tissue (similar to lost-a-fin, C2). (C) control L-690,330 (10 mM)  myo-inositol-injected
(50 mM). (D) L-690,330-injected (10 mM, snail-house-like, C4). Dorsal (E–G) and lateral (I–J) view of24 hpf embryos. (E) Wild-type embryo with arrows
denoting notochord width and stars highlight the lateral portion of one pair of somites. L-690,330-injected embryos display both (F) expanded somites, stars
and (G) thickened notochord, arrows similar to swirl-like phenotypes (C5). Embryos treated with IP3Receptor inhibitors display (H) thickened, wavy
notochord (arrows, XeC). (I) tail curling phenotypes similar to piggy-tail-like (C3) (XeC), and (J) monoclonal blocking antibody-induced bustling and
radialization of tissue over the yolk.
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to interfere with the IP3R channel (Gafni et al., 1997). XeC
treatment of cerebellar microsomes and T lymphocyte cells
at 20 M concentration blocked IP3-dependent calcium
release, but did not have toxic effects and did not interfere
with other calcium release channels (Gafni et al., 1997;
Guse et al., 1999). XeC-induced phenotypes (Table 1) were
similar to those of L-690,330-injected embryos, including
expansion of somites, twisting of the axis, contorted noto-
chord (Fig. 2H, arrows), and twisted shortened tails (Fig.
2I). Furthermore, introduction of the IP3R-blocking anti-
body 1G9 (20 ng/embryo) into zebrafish embryos induced
body plan alterations (Table 1). Anti-IP3R-injected embryos
had defects that include expansion of somites, twisting of
the axis, contorted notochord, and twisted shortened tails
(data not shown). The most severe defect induced by the
blocking antibody is a bustled phenotype. This is the result
of conversion tissue into a radial symmetric mass above the
yolk (Fig. 2J) also observed with L-690,330 and XeC in-
jections (Table 1). Control mouse monoclonal IgG (20 ng/
embryo) injection results in less than 0.5% of the embryos
showing defects (Table 1, n 41), and injection of a mouse
endoplasmic reticulum-specific monoclonal (H-69) did not
generate any phenotype (n  31) (Mengod et al., 1981).
Inhibition of phospholipase C function
To test whether the inhibitor-induced phenotypes de-
scribed above were PI cycle-specific, we targeted a third
component of the PI-path. Phospholipase C (PLC) catalyzes
the release of the IP3 and diacylglycerol second messengers
from membrane-bound inositol lipid (PIP2). We used the
membrane-permeant aminosteroid compound, U-73122, a
potent inhibitor most likely inactivating the PLC isoform
(Hellberg et al., 1996). Control manipulations were with a
biologically inactive analog U-73343. Zebrafish embryos
were incubated in either U-73122 or U-73343 and evaluated
for phenotypes. Embryos incubated in the control solution,
U-73343, appeared the same as wild-type (Fig. 3A), while
embryos incubated in PLC inhibitor, U-73122, demon-
strated cell-motility/gastrulation defects such as a bifurcated
axis (Fig. 3B). Because the amount of inhibitor absorbed
was difficult to determine and to eliminate any possibility
that this intriguing phenotype was due to PLC-inhibitor
action on extracellular membrane proteins, we introduced
the compounds by microinjection. Injection of PLC-inhib-
itor (U-73122) induced mild dorsalization defects (Table 1).
A majority of the phenotypes included loss of ventral tail
Table 1
Summary of PI-inhibition phenotypes
Treatment (dose) Dorsalized phenotypes Morphology
Total
% dorsalized
In Situ
Total %
(Expanded
or ectopic
domains)
Morphological In situ
C1–C3 C4–C5 Bustled 2 axis Boz chordin
L-690,330 (10–12 mM) 2% (4) 13% (27) 5.4% (11) 2.5% (5) — 38% (30/78) 23% (47/203) 38% (30/78)
L-690,330 (3–6 mM) 4% (14) 3.5% (12) 1.8% (6) — 18% (15/85) 28% (18/65) 9.4% (32/342) 22% (33/150)
L-690,330 (10 mM) 
myo-inositol (50 mM)
2.6% (7) 1% (3) — — 0% 0% 3.6% (10/273) 0% (0/29)
XeC (5–10 M) 8% (33) 8.2% (34) 2.4% (10) 1.5% (6) 32% (34/105) 37% (20/54) 20% (83/413) 34% (54/159)
Anti-IP3R(1G9) (20 ng/embryo) 15% (15) 10% (10) 4% (4) — — — 29% (29/99) —
MIgG and H69 (20 ng/embryo) 1.4% (1) — — — — — 1.4% (1/72) —
U-73122 (2–5 M) 9.7% (52) 3.3% (18) — — 18% (9/51) 16% (8/49) 13% (70/538) 27% (17/100)
U-73343 (5–8 M) — 0.5% (2) — — 0% 0% 0.5% (2/405) 0% (0/40)
Control-injected (buffer or GFP) 1.2% (3) — — — 0% 0% 1.2% (3/252) 0% (0/80)
Thapsigargin (2.5–5 M) — 67% (37) 33% (18) — — 100% (26) 100% (55/55) 100% (26/26)
Fig. 3. Phenotypes generated from PLC Inhibition. Lateral view of live
embryos at 24 hpf after incubation in (A) Control (U-73343) and (B).
Inhibitor (U-73122) at 5 magnification. Lateral posterioer view of the tail
after 36 hpf of (C). Control (U-73343) and (D) Inhibitor (U-73122)-
injected embryos at 10 magnification. (E) Embryo coinjected with
U-73122 and myo-inositol. Anterior is to the left in all panels.
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tissue, reduced circulation, and kinks in the notochord (Fig.
3D). At the highest injection dose (5 M), more severe
phenotypes were observed, such as the tail curling over the
trunk and extreme ovoid-shaped embryos, some with lateral
expansion of the somites (Fig. 3E). Less than 1% of control-
injected (U-73343, 5–8 M) embryos demonstrated pheno-
types (Table 1). Consistent with the weaker phenotypic
effects, U-73122-treated embryos did not show any pro-
longed inhibition of endogenous calcium release greater
than 5–6 min.
Dose-dependence and window of sensitivity to PI cycle
inhibition
PI cycle inhibition at the three steps tested all generated
a similar dose-dependent range of phenotypes. Fig. 4 dem-
onstrates the phenotypic response to different doses of
L-690,330. Severe defects occur more frequently at higher
doses, consistent with the increased duration of calcium
release inhibition. Phenotypes of L-690,330-injected em-
bryos are grouped into low (3–5 mM) and high (10–12 mM)
dosage categories. Mild dorsalization defects (C1–C3) are
common at the low doses of L-690,330 treatment (Fig. 4,
striped bars), while higher L-690,330 doses demonstrate an
increased number of severe dorsalization defects (C4–C5)
(Fig. 4, black bars). In addition to the C1–C5 classes of
dorsalization defects, another severe phenotype, radializa-
tion of tissue over the yolk, was observed frequently at the
higher dose (Table 1). Pharmacological depletion of inositol
is rescued by supplying the substrate myo-inositol, in that
the frequency of 10 mM L-690,330-induced defects drops
from 23 to 3.6% when co injected with myo-inositol (Fig. 4,
gray bar, Table 1). The myo-inositol rescue is specific to
inhibition at the inositol turnover step because coinjection
of myo-inositol does not rescue IP3R inhibition (1G9 or
XeC) or PLC (U-73122) inhibition (Fig. 3E).
There is also a window of sensitivity to PI cycle inhibi-
tion. Embryos treated between the 1- and 16-cell stage
display dorsalization and axis defects, while embryos ex-
posed to inhibitor after the 128/256-cell stage appear the
same as wild-type (Fig. 5A) or display anterior head defects
with fusion of the eyes (Fig. 5B, star). These data are
consistent with the observation of anterior defects with
reduced eyes in zebrafish embryos treated with lithium after
mid-blastula transition (Stachel et al., 1993).
Depletion of intracellular calcium stores
Although morphological analyses implicate a role for
PI-cycle requirement for D-V patterning, the overall per-
centage of response is relatively low. That could imply that
the inhibitor-induced suppression of calcium release is not
robust. The suppression of calcium release may not persist
for the duration of the calcium-sensitive period and treated
embryos could recover once calcium transients resume.
Additionally, our delivery by microinjection may not target
all the cells. Since delivery by microinjection is limited to
earlier stages, we utilized a reagent that uniformly and
effectively depletes intracellular calcium in zebrafish em-
bryos for a prolonged period. Thapsigargin is an inhibitor of
a Ca2-ATPase (Thastrup et al., 1990, 1994) that is required
to pump Ca2 back into the endoplasmic reticulum (ER).
Diabling the ER-specific Ca2-ATPase results in loss of
ER-calcium stores. Addition of 5 M thapsigargin to the
medium of Fura-injected embryos results in an intial burst
of calcium levels, followed by little or no calcium release
activity, presumably due to depletion of internal stores.
After incubation in thapsigargen for 1 h, the morphological
phenotypes at 24 hpf are either C5 class of dorsal defects or
severely radialized similar to the IP3R-inhibited embryos
shown in Fig. 2J. Once more, the penetrance is 100% with
all embryos displaying dorsalized phenotypes (n  55).
Thapsigargin treatment led to the most rapid effects of all
the treatments as well as the most lethal. In zebrafish, there
are several dynamic and distinct phases of calcium release
during development. After fertilization, there are dramatic
calcium increases associated with the forming cleavage fur-
row during the first few cell cycles (Chang and Meng, 1995;
Slusarski and Corces, 2000; Slusarski et al., 1997b; Webb et
al., 1997). Exposure to thapsigargin prior to the 32- to
64-cell stage led to cleavage arrest.
PI cycle inhibition leads to expanded and ectopic dorsal
domains
We found that PI cycle inhibition can also induce a
duplicated axis (Table 1). The L690,330-injected embryo in
Fig. 5C has a duplicated head with the fourth eye located out
of the focal plane. In the XeC-induced axis duplication
shown, the primary axis is folded back over the tail (Fig.
Fig. 4. Dose response to inhibition of inositol turnover. Dorsalized pheno-
types generated from L-690,330-injected embryos were grouped into 3–6
mM and 10 mM doses. The C1–C5 dorsalization classification (x-axis)
plotted against the percent of embryos displaying the phenotype (y-axis).
The gray bar is the control-injected (L-690,330 coinjected with myo-
inositol), hashed bars represent low dose of L-690,330 treatment, and the
black bars represent high L-690,330 dose. The higher dose shifts the
phenotypic response toward the more severe C4 and C5 classes.
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5D, black arrow), while the partial secondary axis (includ-
ing otic vesicles and a second beating heart) is to the left
(Fig. 5D, white arrow). Although a small number of em-
bryos-demonstrate duplicated axes (n 11), we believe this
to be a noteworthy phenotype in that it lends insight into the
mechanism of calcium modulation and implicates processes
important for dorsal organizer activity. To confirm that the
morphological defects were the result of expanded or ec-
topic dorsal domains in the treated embryos earlier in de-
velopment, we analyze distibution of a shield-specific
marker, chordin. The bone morphogenetic protein antago-
nist chordin (Miller-Bertoglio et al., 1997) is expressed in
the dorsal shield region at 50% epiboly (5.25 hpf). In an
animal pole view, chordin expression normally encom-
passes one-quarter of the circumference of the embryo (Fig.
6A, arrows). Expanded chordin domains are generated with
all the treatments (Table 1). The chordin expression domain
expands to approximately half the circumference of the
embryo in the XeC-treated embryo shown (Fig. 6B). Severe
dorsalization is highlighted by chordin expression encir-
cling the embryo (Fig. 6C, L-690,330-treated). Thapsigar-
gin-treated embryos show strong radialization in all treated
embryos (Fig. 6D). Chordin expression domains appear the
same as wild-type in control-injected embryos (Fig. 6E: 10
mM L-690,330 with 50 mM myo-inositol, dorsal view). As
with the observation of morphological ectopic axes, ectopic
chordin domains (Fig. 6F, L-690,330-treated, dorsal view)
are observed on both L-690,330- and XeC-treated embryos.
PI cycle inhibition results in expanded domains of
-catenin
PI cycle inhibitor-induced phenotypes resemble pheno-
types in zebrafish embryos overexpressing -catenin
(Sumoy et al., 1999). To investigate the mechanism of
hyperdorsalization, we analyzed Wnt/-catenin signaling
components. Activation of the canonical Wnt pathway sta-
bilizes cytoplasmic -catenin protein which then functions
in establishing the dorsal organizer. To test whether sup-
pression of PI cycle activity leads to an increase in Wnt/-
catenin activity, we monitored nuclear localization of the
-catenin protein. Embryos injected with PI cycle inhibitors
(described above) were processed at the sphere stage for
immunolocalization of -catenin (Schneider et al., 1996). In
the zebrafish blastula, there is an accumulation of nuclear
-catenin in the yolk syncytial layer underlying the future
dorsal side of the embryo. By the sphere stage, there is an
uptake of nuclear -catenin in the overlying blastoderm
(Schneider et al., 1996). In Fig. 7, panels A, D, and I
represent single sections of a z-axis series of confocal im-
ages oriented in an animal pole view, while panels B, C,
E–H, and J–M are images captured at higher magnification
Fig. 5. Window of sensitivity and axis duplication induced by PI cycle inhibition. Lateral view with anterior to the left of live embryos after 48 hpf. Late
treatment of zebrafish embryos with PI cycle inhibitors results in anterior head defects and fusion of the eyes (U-73122, 2.4%; XeC, 3.2%; and L-690,330,
5.7%). (A) Control embryo with star denoting one eye in focus. (B) Embryo injected at a late stage with L-690,330 with the star denoting a reduced eye with
partial cyclopia. PI cycle inhibition generates duplicated dorsal structures. (C) L690,330-injected embryo with duplicated heads (arrows). The fourth eye is
slightly out of the focal plane (white arrow). (D) XeC-injected embryo with the partial secondary axis including ectopic ears (white arrow) and abnormal
pericardial cavity. The primary axis folded over the yolk (black arrow).
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with dots noting nuclear -catenin (only cells on the pe-
riphery are highlighted). In sphere-stage wild-type embryos,
we typically observe -catenin-positive nuclei spanning 20-
40% the circumference of the embryo (average of 11  4
-catenin-positive nuclei/embryo, n  15). Lower case b
and c in Fig. 7A highlight nuclear -catenin and the future
dorsal side of a wild-type embryo. The same region of
nuclear -catenin is shown at higher magnification in Fig.
7B and C (dots). XeC-treated embryos have an approximate
four-fold increase in -catenin-positive nuclei per embryo
(Fig. 7D) (average of 47  16 nuclei/embryo, n  10).
Images collected of the same XeC-treated embryos at higher
magnification demonstrate prominent levels of nuclear
-catenin in domains that span 50% the circumference of
the embryo (Fig. 7E–H). L-690,330-injected embryos also
display a greater number of -catenin-positive nuclei (av-
erage of 87  32 -catenin-positive nuclei/embryo, n  5).
Domains of nuclear -catenin can be found all around the
circumference of the embryo (Fig. 7I) with several regions
of nuclei clusters (Fig. 7J–M). PLC-inhibited embryos show
a mild increase in the amount of nuclear -catenin with an
average of 17 -catenin-positive nuclei/embryo (n 3, data
not shown) consistent with the mild dorsalization defects
discussed earlier (Table 1). The increase in the number of
-catenin-positive nuclei in PI cycle-inhibited embryos sug-
gests that calcium release is antagonistic to canonical Wnt/
-catenin activity; with loss of PI cycle-mediated calcium
release, the domain of nuclear -catenin expands.
To confirm increased Wnt/-catenin activity at the mo-
lecular level, we analysed the distribution of the homeodo-
main protein bozozok (boz; also called dharma and
niewkoid) (Fekany et al., 1999; Koos and Ho, 1998; Ya-
manaka et al., 1998), a downstream target of Wnt/-catenin
signaling (Ryu et al., 2001). Endogenous boz zygotic ex-
Fig. 6. Expanded and ectopic chordin domains in PI-inhibited embryos.
Expression pattern of chordin at 50% epiboly in PI-inhibited embryos.
Animal pole view with dorsal to the right (A–D). (A) Wild-type embryo,
arrows denote the lateral domain of chordin expression. Embryo treated
with (B) IP3R inhibitor (XeC) with arrows showing expanded chordin
domain. (C) L-690,330-injected and (D) thapsigargin-treated embryos with
radialized chordin expression. Dorsal view of (E) Control (10 mM
L-690,330  50 mM myo-inositol-injected) embryo with a relatively nor-
mal chordin expression domain (stars) and of (F) L-690,330-injected em-
bryo with an ectopic domain, arrow.
Fig. 7. PI cycle inhibition increases the extent of nuclei containing -cate-
nin at sphere stage. Immunolocalization of -catenin protein in sphere-
stage embryos. Four-micron optical sections were collected with confocal
microscopy. Embryos were oriented with the animal pole up. (A, D, and I)
20 magnification; (B, C, E–H, J–M) 63 magnification. The approxi-
mate locations of the higher magnification images are mapped, in lower
case, onto the 20 image. (A) Wild-type embryo at sphere stage, 20
representation for orientation. Representative 63 images of the same
embryo collected around the circumference are shown in (B) and (C) with
dots noting the location of nuclear -catenin. -Catenin-positive nuclei are
localized to a region of approximately one-third the circumference of the
embryo. (D) XeC-injected embryo at 20 for orientation with individual
high magnification images are shown in (E–H), dots noting intense nuclear
-catenin localization. XeC-treated embryos have expanded nuclear
-catenin domains that span more than 50% the circumference of the
embryo. The L-690,330-injected embryo in (I) has nuclear -catenin in
ectopic locations that span the circumference of the embryo. Clusters of
-catenin-positive nuclei are present in (L) and (M) (L, M) -Catenin
localization at region opposite the location of (J) and (K). Numerous
internal cells with nuclear -catenin are not marked with dots.
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pression initiates at the dorsal blastoderm and dorsal yolk
syncitial layer denoting the future zebrafish organizer re-
gion. Sphere-stage control-injected embryos express boz in
a small group of cells at the dorsal margin (Fig. 8A, stars).
XeC-injected embryos have expanded (Fig. 8B, stars)
and/or ectopic boz expression domains (Fig. 8B, arrows)
(Table 1). L-690,330-injected embryos display a similar
frequency of expanded or ectopic domains (Table 1), while
3.5% of the L-690,330-treated embryos display radialized
boz expression as demonstrated by the staining around the
circumference of the embryo in an animal pole view (Fig.
8D, dashed line).
Discussion
In this study, we target several points in the PI pathway
with multiple, chemically distinct inhibitors in order to
definitively demonstrate that PI cycle activity impacts D-V
patterning. We describe an increase in dorsal tissue both at
the morphological and the molecular level due to PI-cycle
and calcium release inhibition. This expansion of dorsal
tissue is independent of both the inhibitor and the target in
the PI-cycle as well as an indication that PI cycle activity is
required during the cleavage stage for proper body plan
formation. The ectopic and/or expanded dorsal signaling
domains have increased amounts of nuclear -catenin and
bozozok expression, suggesting that the role of PI cycle-
mediated calcium release in establishing proper D-V pat-
terning is via antagonistic interactions with Wnt/-catenin
signaling.
Based on the sensitivity of a subset of zebrafish blas-
tomeres to lithium at the 32-cell stage (Aanstad and Whi-
taker, 1999), we would predict affecting the PI cycle-sen-
sitive side of the embryo half of the time. A 50% frequency
of dorsalized defects was observed with lithium treatments
(Aanstad and Whitaker, 1999); however, we observe a
lower frequency with our PI cycle inhibitor studies. Dorsal-
specific gene expression monitored at both 3 and 5 h after
treatment demonstrated a much higher percentage of expan-
sion of dorsal tissue (34–38% for XeC and L-690,330-
treated embryos) than morphological analyses. The lower
than 50% predicted frequency of phenotypes in this study
may reflect high turnover of the microinjected reagents, as
demonstrated by the loss of L-690,330 and U-73122 po-
tency over time when analyzed in vivo. In support of this,
prolonged depletion of the endoplasmic reticulum calcium
stores leads to severely dorsalized defects 100% of the time.
Lithium-induced dorsalization is more potent than our
PI-cycle inhibitors due to its action on two distinct pathways
that both influence -catenin stabilization, as well as its
potential impact on other proteins (Manji et al., 1997; Saito
et al., 1995). Lithium not only blocks PI cycle turnover
(Williams et al., 2002), but also inhibits glycogen synthase
kinase-3 (Gsk-3) activity (Klein and Melton, 1996; Stam-
bolic et al., 1996). Downregulation of Gsk-3 activity leads
to the stabilization and accumulation of -catenin in the
nucleus. Therefore, lithium treatment stabilizes -catenin
protein by inhibition of Gsk activity and by removing Ca2
mediated antagonism. Given that PI cycle-mediated Ca2
fluxes occur during the cleavage stage, Ca2 modulation is
a prime candidate for restriction of Wnt/-catenin activity
during early D-V patterning.
The mechanism of calcium-dependent antagonism of
-catenin localization may lie in activating downstream
proteins. Wnt-5A misexpression in zebrafish stimulates cal-
cium release (Slusarski et al., 1997b) and thus defines a
physiological output of the Wnt/Ca2 class. Stimulation of
the Wnt/Ca2 pathway has been shown to activate calcium-
sensitive proteins, including protein kinase C (PKC), Ca2/
calmodulin-dependent kinases (CaMK), and calcineurin-de-
pendent nuclear factor of activated T cells (NF-AT) (Kuhl et
al., 2000a; Saneyoshi et al., 2002; Sheldahl et al., 1999).
Activated PKC and CaMKII interact with different compo-
nents of the Wnt/-catenin path to antagonize convergent
extension movements (Kuhl et al., 2001) and mediate an-
tagonistic interactions by activating a mitogen-activated
protein kinase cascade (Ishitani et al., 2003). The Drosoph-
ila segment polarity gene naked cuticle (nkd) encodes an EF
hand calcium binding protein that is antagonistic to Wnt/-
catenin signaling (Rousset et al., 2001; Wharton et al., 2001;
Yan et al., 2001; Zeng et al., 2000). Regulation of Nkd
protein activity may be another interaction point sensitive to
ion fluxes that can lead to regulation of -catenin protein
localization. In summary, Ca2 modulation functions in
dorsal–ventral axis specification and its biological effects
are in part due to negative regulation of Wnt/-catenin
signaling.
Fig. 8. Ectopic domains of bozozok in PI-inhibited embryos. Whole-mount
in situ hybridization of bozozok at sphere-stage embryos following PI cycle
inhibition. Dorsal view of (A) untreated with stars noting the endogenous
boz domain and (B). XeC-injected embryo with a robust primary boz
expression domain (stars) and ectopic domains (arrow). Animal pole views
of (C) control embryo, stars noting the endogenous expression and (D)
L-690,330-treated with the radialization of boz expression highlighted by a
dashed line.
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